BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services

Catalent to Acquire Metrics Contract Services for $475 Million

Catalent, Inc. (NYSE: CTLT), the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and sup...

August 23, 2022 | News

Selecxine, a partner of GenScript ProBio, announces FDA clearance of its IND application for innovative antibody drug program (SLC-3010)

In December 2019, GenScript ProBio announced the strategic collaboration with Selecxine for an innovative antibody drug program. The project (SLC-3010...

August 23, 2022 | News

WuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility

First announced in June 2021, this site will be WuXi STA's second facility in the United States, offering expanded capacity and greater flexibili...

August 17, 2022 | News

Merck Becomes One of the First CDMOs to Provide Full Viral Vector Offering with Launch of VirusExpress® 293 Adeno-Associated Virus Production Platform

Reduces process development time by an estimated 40 percent Enables biopharmaceutical companies to increase the speed to clinical manufacturing ...

August 10, 2022 | News

Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15

-Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced the initiation of a Phase 3 clinical study, Vacc...

August 09, 2022 | News

LG Chem Enters Final Stage of Clinical Development for New Gout Drug

In global Phase 3 clinical trial, Tigulixostat will be evaluated in 350 adult gout patients with hyperuricemia for safety and efficacy at Month 6 of treatm...

August 04, 2022 | News

GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine

GreenLight's messenger RNA production process is transferable to large-scale equipment and CMO facilities Technology transfer and scale-up from lab benc...

August 02, 2022 | News

Samsung Biologics Reports Second Quarter 2022 Financial Results

Released consolidated financial position of the company based on its full acquisition of Samsung Bioepis completed on April 20, 2022 Achieved recor...

July 28, 2022 | News

Ozgene and Gen-H partner on Ozgene’s new OzBIG targeted humanization capability

Ozgene and Gen-H are pleased to announce our working partnership supporting Ozgene’s new OzBIG capability. Ozgene Pty Ltd is a privately held CRO bas...

July 25, 2022 | News

WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapore

This investment will establish a cutting-edge, fully integrated CRDMO center in Singapore, including a research and development service center and large-...

July 20, 2022 | News

Samsung Biologics to purchase land for its second Bio Campus

Acquires additional land, sized 357,366㎡ valued at KRW 426 billion, for Bio Campus 2 Plans to build Multi-Modal Plant, Open Innovation,...

July 19, 2022 | News

Pulnovo Medical Concludes Successfully First Pre-Sub Meeting with FDA for PADN Global Clinical Trial

Dr. Shaoliang Chen, Chair of Pulnovo Medical's Scientific Advisory Board and pioneer of the PADN technology, attended the meeting and presented the co...

July 18, 2022 | News

GenScript ProBio and DAAN Bio Therapeutics, Sign a Strategic Cooperation MOU for the Discovery and Development of Novel Drugs

Through this agreement, both companies will strategically cooperate in the overall development process, such as discovery, manufacturing, and clinical tria...

July 15, 2022 | News

Novotech Client SK bioscience Achieves SKYCovione(TM) COVID-19 Vaccine Approval in Korea

SK bioscience and GSK recently announced the successful authorization:SK bioscience announced that 'SKYCovione(TM),' South Korea's first COVID-19 vaccine c...

July 14, 2022 | News

Stay Connected